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Nevus Sebaceus Is a Mosaic
RASopathy
Rudolf Happle1
The recent discovery that nevus sebaceus is a mosaic RASopathy represents a
major breakthrough in research on epidermal nevi. In this issue, both Levinsohn
et al. and Sun et al. confirm this advancement with results obtained through
whole-exome sequencing. Further molecular studies will almost certainly show
that sebaceous and keratinocytic nevi are different disorders, although there is
some clinical overlap.
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Nevus sebaceus is common among
epidermal nevi. When involving the
head, lesions consist of linear or patchy,
skin-colored or yellowish plaques with
hairless, orange peel–like surfaces
(Figure 1). In the era of molecular
research, it took a rather long time to
elucidate the genetic basis of this dis-
order. However, the question has been
answered with the identification of post-
zygotic HRAS and KRAS mutations as
the cause of both isolated nevus seba-
ceus and the Schimmelpenning syn-
drome (Groesser et al., 2012). In the
present issue, two American groups
present interesting findings that fully
confirm the results reported by the
European authors.
In this commentary, we shall consider
how this major breakthrough in research
on epidermal nevi was accomplished
and the new questions that this
advancement poses.
A discovery achieved by the candidate
gene method
One year ago, the group of Christian
Hafner from Regensburg (Germany)
reported, in collaboration with Spanish
scientists, that they had found an acti-
vating HRAS mutation in a patient who
had a systematized keratinocytic nevus
associated with early development of
urothelial cancer (Hafner et al., 2011).
Subsequently, screening of keratinocytic
nevi revealed activating RAS mutations
in 39% of cases, with the HRAS p.G13R
substitution being a hotspot mutation
(Hafner et al., 2012). As a further step,
the authors then decided to look, using
a candidate gene approach, for the
presence of RAS mutations in nevus
sebaceus.
By using Sanger sequencing and a
RAS snapshot multiplex assay, they
found HRAS or KRAS mutations in 63/
65 sebaceous nevi (97%). In all, 95% of
lesions harbored an HRAS mutation,
with HRAS c.37G4C representing a
hotspot mutation encountered in 91%
of cases. KRAS mutations were found in
5% of sebaceous nevi. All of these
mutations were present in a heterozy-
gous state.
In a patient with Schimmelpenning
syndrome, the authors found the HRAS
c.37G4C mutation exclusively in
lesional skin. In another patient with
this syndrome, a KRAS mutation was
noted to be present in lesional tissue
only. When analyzing secondary tumors
that had developed in sebaceous nevi,
they detected the same HRAS mutations
that were present in the underlying nevi.
The authors concluded that both nevus
sebaceus and Schimmelpenning syn-
drome could be categorized as mosaic
RASopathies.
See related articles on pg 824 and 827 Confirming the etiology of nevus
sebaceus by whole-genome sequencing
Levinsohn et al., 2013 (this issue)
present a complementary study that
provided similar results. In contrast to
the candidate gene approach used by
Groesser et al., the authors performed
whole-exome sequencing of DNA
obtained from blood and lesional
tissues. Again, HRAS c.37G4C was
found to be a hotspot mutation. Further-
more, the KRAS mutations c.35G4A
and c.35G4T were encountered in
two cases. They were identical to the
two KRAS alleles described by Groesser
et al. Notably, the authors confirmed
the absence of any loss of heterozy-
gosity.
In several specimens obtained from
tumors that arose on sebaceous nevi, the
authors confirmed the presence of
HRAS mutations.
Confirming the etiology of
Schimmelpenning syndrome
In another paper, Sun et al., 2013 (this
issue) present molecular data obtained
in a 38-year-old woman with multiple
features of Schimmelpenning syndrome,
including severe neurological defects
and pronounced scoliosis. In her third
decade, she experienced a cerebral
stroke. Samples obtained from her
sebaceous nevus were analyzed by
exome sequencing. Again, the authors
encountered the HRAS hotspot mutation
c.37G4C. Moreover, they found this
hotspot mutation in 24/31 archived
tissue samples obtained from indepen-
dent sebaceous nevi. Other HRAS or
KRAS mutations were documented in
three of these specimens. In total, 89%
of samples showed HRAS or KRAS
mutations.
Comparison with other mosaic
RASopathies
The ‘‘RASopathies’’ represent a group of
autosomal dominant syndromes charac-
terized by dysregulation of the RAS/
MAPK pathway (Tidyman and Rauen,
2009). Recently, the term ‘‘mosaic RAS-
opathies’’ was proposed for disorders
resulting from activation of this
pathway by mosaic mutations (Hafner
et al., 2012). A list of the reported
mosaic RASopathies is presented in
Table 1. Nevus sebaceus belongs to a
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group of disorders caused by lethal
mutations that survive through mosai-
cism (Happle, 1987). A large part of
keratinocytic nevi are similarly caused
by RAS mutations that, when present as
a germ-line mutation, would be lethal
for an embryo early in development.
A mosaic RASopathy reflecting a non-
lethal mutation is exemplified by seg-
mental forms of Costello syndrome. This
autosomal dominant multisystem birth
defect is characterized by various cuta-
neous lesions such as generalized hyper-
pigmentation, loose skin (especially
redundant on the hands), periorificial
papillomas, velvety appearance of palms
and soles that show relatively deep
creases, and acanthosis nigricans–like
hyperkeratosis. The patients’ hair is
sparse, brittle, and curly. In a 15-year-
old girl with features of Costello syn-
drome, Gripp et al. (2006) found seg-
mental areas of hyperpigmentation on
her trunk and right arm, streaky hyper-
pigmention on the dorsal aspect of her
left foot, and segmental hyperkeratosis
involving her left sole. The authors found
an HRAS mutation p.G12S in sampled
buccal cells, whereas her blood leuko-
cytes showed the wild type only. A simi-
lar case of segmental Costello syndrome
caused by a mosaic HRAS mutation was
reported by Sol-Church et al. (2009).
In some other autosomal domi-
nant RASopathies, a type 2 segmental
involvement, being superimposed on
the ordinary nonsegmental pheno-
type (Happle, 1997), can be taken as
proven at the molecular level. In the first
report on a phenotype that later was
named Legius syndrome, Brems et al.
(2007) included a photograph suggest-
ing a type 2 segmental manifestation in
the form of an extensive, flag-like cafe´-
au-lait hyperpigmentation being sharply
demarcated in the midline. This large
unilateral patch may be best explained
by an early event of allelic loss (Fo¨lster-
Holst et al., 2012).
Writzl et al. (2007) described
LEOPARD syndrome in a man who fath-
ered a son whose skin was similarly
pigmented except for the left side of his
thorax, back, and left arm, which were
completely devoid of lentigines. Among
several possibilities, the authors discus-
sed revertant mosaicism, which appears
to be the most likely explanation.
Are sebaceous and keratinocytic nevi
variants of the same disorder?
When a systematized sebaceous nevus
involves several parts of the body, the
components affecting the trunk and
limbs usually do not show hyperplasia
of sebaceous glands, which is why these
portions of the nevus may be indistin-
guishable from a keratinocytic nevus
(Happle, 1995). This has led some
authors to the erroneous belief that
sebaceous and keratinocytic nevi are
variants of the same disorder (Solomon
and Esterly, 1975; Waltz et al., 1999;
Moss and Shadihullah, 2010). Mole-
cular studies, however, have shown
that this view cannot be sustained
because a quite different spectrum of
HRAS mutations is found in keratino-
cytic nevi (Hafner et al., 2012). When
such nevi involve the head, they do not
show hyperplasia of sebaceous glands.
Nevus sebaceus can no longer be
regarded as a paradominant trait
Familial aggregation of nevus sebaceus
has been reported relatively frequently.
Clinical Implications
 Nevus sebaceus, including Schimmelpenning syndrome, is caused by
postzygotic HRAS or KRAS mutations.
 The disorder can be added to a list of mosaic RASopathies that includes a
specific group of keratinocytic nevi and mosaic cases of Costello syn-
drome, neurofibromatosis 1, Legius syndrome, rhodoid nevus syndrome,
and LEOPARD syndrome.
 Familial nevus sebaceus can no longer be explained by the concept of
paradominant inheritance, because the underlying RAS mutations have
been shown to be present in a heterozygous state.
Figure 1. Systematized sebaceous nevus involving the scalp and the face (courtesy of Dr Mo´nica
Zambrano, Quito, Ecuador).
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As random coincidence appeared to be
unlikely, we suggested the concept of
paradominant transmission (Happle and
Ko¨nig, 1999). Accordingly, a heterozy-
gous individual would be phenotypi-
cally healthy. The nevus would only
develop when early postzygotic recom-
bination gave rise to loss of the corres-
ponding wild-type allele. As nevus
sebaceus has now been shown to be
caused by a heterozygous state of post-
zygotic RAS mutations, the concept of
paradominance of this trait must be
regarded as incorrect. Perhaps the
familial cases may be explained by an
unstable premutation, but readers should
understand that at this point I prefer not
to propose additional hypotheses.
Woolly hair nevus: another mosaic
RASopathy?
Woolly hair nevus is characterized by
linear areas of curly or woolly hair
noted within straight scalp hair. The
surface of the involved skin may appear
normal, or the lesion may belong to a
systematized keratinocytic nevus and
thus may be hyperkeratotic. As curly
hair is a feature of various RASopathies
such as Costello syndrome, Noonan
syndrome, and cardiofaciocutaneous
syndrome, woolly hair nevus should be
examined for HRAS mutations. In this
context, however, it is tempting to spec-
ulate that keratinocytic nevi caused by
HRAS mutations may give rise to curly
or woolly scalp hair, whereas other
keratinocytic nevi may not.
Conclusion
The knowledge that nevus sebaceus,
including Schimmelpenning syndrome,
is caused by HRAS and KRAS mutations
leads to several important questions.
Why is nevus sebaceus characterized
by dichotomous clinical and histopatho-
logical changes, depending on the
involved area of the body? How can
we explain familial nevus sebaceus, as
the theory of paradominant inheritance
is no longer valid for this trait? Do other
birthmarks, such as woolly hair nevus,
represent additional candidates to be
tested for the presence of RAS muta-
tions? Addressing these problems will
yield further insight into the relationship
between dysregulation of the RAS/
MAPK pathway and skin disorders.
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